user

Stable pulmonary function after haploidentical stem cell transplantation with post-transplant cyclophosphamide: a single center experience

被引：0
|
作者：
Paviglianiti, Annalisa [1 ,2 ]
Sestili, Simona [1 ]
Bianchessi, Antonio [1 ,3 ,4 ]
Memoli, Mara [1 ,5 ]
Dulery, Remy [1 ]
Banet, Anne [1 ]
Van De Wyngaert, Zoe [1 ]
Belhocine, Ramdane [1 ]
Ledraa, Tounes [1 ]
Malard, Florent [1 ]
Mohty, Mohamad [1 ]
Brissot, Eolia [1 ]
机构：
[1] Sorbonne Univ, Serv Hematol Clin & Therapie Cellulaire, Hop St Antoine, 184 Rue Faubourg St Antoine, F-75012 Paris, France
[2] Univ Campus Biomed, Rome, Italy
[3] Univ Pavia, Dept Mol Med, Pavia, Italy
[4] Fdn IRCCS Policlin San Matteo, Div Hematol, Pavia, Italy
[5] Univ Naples Federico II, Hematol & Hematopoiet Stem Cell Transplant Ctr, Dept Med & Surg, Naples, Italy
来源：
LEUKEMIA & LYMPHOMA | 2022年 / 63卷 / 02期
关键词：
PFT; HAPLO; pulmonary function; pulmonary function tests; HSCT; lung function score; BRONCHIOLITIS-OBLITERANS; LUNG-FUNCTION; COMPLICATIONS; DISEASE; ABNORMALITIES; MORTALITY; PREVENTS; INDEX;
D O I：
10.1080/10428194.2021.1984460
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Prior studies have reported pulmonary function tests (PFT) before and after related and unrelated allogeneic hematopoietic stem cell transplantation (HSCT). However, limited data exist on the evaluation of lung function after haploidentical stem cell transplantation (HAPLO) with post-transplant cyclophosphamide (PTCY). We retrospectively reported the evaluation of PFTs at screening before HAPLO in 80 patients at 100 days and 1 year of follow-up. The proportion of surviving patients with available PFTs at 100 days and 1 year were 86% and 68%, respectively. During the follow-up period, four patients met the criteria for bronchiolitis obliterans syndrome and two for interstitial lung disease. Overall survival was 73% (95% CI 62-82%) at 2 years. We observed a significant reduction in diffusing capacity of the lungs for carbon monoxide (DLCO) corrected for the most recent hemoglobin concentration (DLCOc) at 100 days after HAPLO. However, an overall substantial stable pulmonary function was observed at 1 year.
引用
收藏
页码：443 / 449
页数：7
相关论文
共 50 条
  • [41] Haploidentical hematopoietic stem cells transplantation using post-transplant cyclophosphamide in inborn errors of immunity: Experience in a reference center in Colombia
    Medina, Diego
    Castro, Jhonier Orlando
    Castro, David Esteban
    Beltran, Estefania
    Manzi, Eliana
    Franco, Alexis Antonio
    Olaya, Manuela
    [J]. BIOMEDICA, 2024, 44 : 1 - 32
  • [42] Hemophagocytic syndrome following haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide
    Sarita Rani Jaiswal
    Aditi Chakrabarti
    Sumita Chatterjee
    Sneh Bhargava
    Kunal Ray
    Suparno Chakrabarti
    [J]. International Journal of Hematology, 2016, 103 : 234 - 242
  • [43] POOR GRAFT FUNCTION AFTER HAPLOIDENTICAL TRANSPLANT NOT MANIPULATED WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE
    Martin-Rojas, R.
    Gomez-Centurion, I
    Bailen, R.
    Munoz, C.
    Sabell, S.
    Dorado, N.
    Oarbeascoa, G.
    Monsalvo, S.
    Rubio, E.
    Martinez-Laperche, C.
    Buno, I
    Anguita, J.
    Diez-Martin, J. L.
    Kwon, M.
    [J]. HAEMATOLOGICA, 2020, 105 : 114 - 115
  • [44] Hemophagocytic syndrome following haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide
    Jaiswal, Sarita Rani
    Chakrabarti, Aditi
    Chatterjee, Sumita
    Bhargava, Sneh
    Ray, Kunal
    Chakrabarti, Suparno
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 103 (02) : 234 - 242
  • [45] Haploidentical Stem Cell Transplantation With Post-transplant Cyclophosphamide for Pediatric Acute Leukemia is Safe and Effective
    Sharma, Anil
    Rastogi, Neha
    Chatterjee, Goutomi
    Kapoor, Rohit
    Nivargi, Sagar
    Yadav, Satya P.
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (07) : E1033 - E1036
  • [46] Haploidentical haematopoietic stem cell transplantation combined with post-transplant cyclophosphamide in neuronal ceroid lipofuscinosis: Experience in eight patients
    Song, Zeliang
    Cui, Xiaodai
    Zhang, Zhaoxia
    Liu, Rong
    Shi, Xiaodong
    [J]. MEDICINA CLINICA, 2024, 162 (05): : 244 - 249
  • [47] Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
    Mohty, Razan
    Al Kadhimi, Zaid
    Kharfan-Dabaja, Mohamed
    [J]. HEMATOLOGY, 2024, 29 (01)
  • [48] Post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation: A single-center experience
    Luo, Lan
    Zhang, Lin
    Cai, Bo
    Li, Honghua
    Huang, Wenrong
    Jing, Yu
    Zhu, Haiyan
    Zhao, Yu
    Bo, Jian
    Wang, Quanshun
    Han, Xiaoping
    Yu, Li
    Gao, Chunji
    [J]. ANNALS OF TRANSPLANTATION, 2014, 19 : 6 - 12
  • [49] T-Cell Replete Haploidentical Stem Cell Transplantation with Post Transplant Cyclophosphamide in Hemoglobinopathies: A Single Centre Experience
    Yadav, Satya Pralcash
    Thakkar, Dhwanee
    Rastogi, Neha
    Kohli, Shruti
    Nivargi, Sagar
    Katewa, Satyendra
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S264 - S265
  • [50] Post-transplant treatment for patients with unfavourable acute leukaemia after haploidentical stem cell transplantation.Single centre experience
    Paina, O.
    Stancheva, N.
    Bondarenko, S.
    Slesarchuk, O.
    Vavilov, V.
    Babenko, E.
    Ivanova, N.
    Alyanskiy, A.
    Bagge, D.
    Semenova, E.
    Zubarovskaya, L.
    Afanasyev, B.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S112 - S112
12345